Clinical Trial Update: Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome

View source ↗

Summary

This clinical trial update reports that immature platelet fraction may serve as a biomarker to predict outcomes in HELLP syndrome, and the study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hellp Syndrome
• Preeclampsia
• Thrombotic Microangiopathy

Snippet

Sponsor: AYMAN ABDELKADER MOHAMED ABDELKADER | Conditions: Pre-Eclampsia, Severe, HELLP Syndrome | Status: COMPLETED